Ying Huang is currently the Chief Executive Officer and a member of the Board of Directors at Legend and Quanta Therapeutics. Dr. Huang joined Legend in July 2019 as the Chief Financial Officer.
Dr. Huang brings over nine years of experience in research and development at major multinational pharmaceutical companies and 12 years of experience as a biotechnology analyst on Wall Street.
Prior to Legend, Dr. Huang was the Managing Director and Head of Biotech Equity Research at Bank of America Merrill Lynch, where he led a team of analysts covering more than 30 biotechnology companies across a wide range of therapeutic areas. His expertise was acknowledged by the Institutional Investor Survey, where he was ranked as a top biotechnology analyst on Wall Street. Before that, he held positions of increasing responsibility at Barclays, Gleacher & Co., Credit Suisse, and Wachovia. Besides providing investment research to investors, Dr. Huang and his team conducted due diligence for numerous successful initial public offerings (IPOs) and follow-on offerings in the biotechnology sector.
Before his tenure on Wall Street, Dr. Huang served as a Principal Scientist at Schering-Plough Corporation, focusing on small molecule drug discovery in the therapeutic areas of the cardiovascular and central nervous system. He has co-authored multiple patents and peer-reviewed publications.
Dr. Huang received his Ph.D. in bio-organic chemistry from Columbia University. He also studied in the Special Class for the Gifted Young at the University of Science and Technology of China and Columbia Business School.
What is Ying Huang's net worth?
The estimated net worth of Ying Huang is at least $4.72 million as of March 25th, 2026. Dr. Huang owns 247,438 shares of Legend Biotech stock worth more than $4,724,334 as of April 1st. This net worth evaluation does not reflect any other assets that Dr. Huang may own. Learn More about Ying Huang's net worth.
How do I contact Ying Huang?
Has Ying Huang been buying or selling shares of Legend Biotech?
Ying Huang has not been actively trading shares of Legend Biotech in the last ninety days. Most recently, Ying Huang sold 9,936 shares of the business's stock in a transaction on Wednesday, March 25th. The shares were sold at an average price of $8.77, for a transaction totalling $87,138.72. Following the completion of the sale, the chief executive officer now directly owns 247,438 shares of the company's stock, valued at $2,170,031.26. Learn More on Ying Huang's trading history.
Are insiders buying or selling shares of Legend Biotech?
During the last year, insiders at the sold shares 1 times. They sold a total of 9,936 shares worth more than $87,138.72. The most recent insider tranaction occured on March, 25th when CEO Ying Huang sold 9,936 shares worth more than $87,138.72. Insiders at Legend Biotech own 0.0% of the company.
Learn More about insider trades at Legend Biotech. Information on this page was last updated on 3/25/2026.
